Seagen Jumps 11% on Pfizer Acquisition Rumors – Should You Buy the Hype Early?

By |2023-12-07T21:00:34+00:00February 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

As Pfizer’s sales continue to struggle, they’ve turned to acquisitions as a means of making up for lost revenue. And one company they have their eye on is Seagen - a cancer drugmaker with a market cap of roughly $30 billion. Last year, Seagen was rumored to be acquired by Merck. This deal could [...]